中华放射医学与防护杂志
中華放射醫學與防護雜誌
중화방사의학여방호잡지
Chinese Journal of Radiological Medicine and Protection
2009年
3期
286-288
,共3页
段玉龙%范向辉%史中州%赵诚%丁朝鹏%解洪泉%张小力
段玉龍%範嚮輝%史中州%趙誠%丁朝鵬%解洪泉%張小力
단옥룡%범향휘%사중주%조성%정조붕%해홍천%장소력
肿瘤转移%脑%立体定向放射疗法%全脑放射疗法%预后
腫瘤轉移%腦%立體定嚮放射療法%全腦放射療法%預後
종류전이%뇌%입체정향방사요법%전뇌방사요법%예후
Neoplasm metastais%Brain%Stereotactic radiotherapy%Whole brain radiotherapy%Prognosis
目的 分析X刀分次立体定向放疗(FSRT)联合全脑照射(WBRT)治疗脑转移瘤疗效.方法 回顾性分析51例脑转移瘤FSRT+WBRT和35例脑转移瘤单纯WBRT的结果,比较分析两者有效率、生存率的差异.结果 FSRT+WBRT、WBRT组完全缓解率分别为49%、26%(P<0.05),中位生存期分别为(11.0±1.5)、(6.5±0.5)个月(P<0.05),18个月生存率分别为24%、9%(P<0.05).两组有效率(8%、71%,P0.05)和6、12个月生存率(63%、41%,51%、23%,P0.05)相似.结论 X刀FSRT联合WBRT治疗脑转移瘤损伤小、安全、延长生存期,疗效优于单纯全颅放疗.
目的 分析X刀分次立體定嚮放療(FSRT)聯閤全腦照射(WBRT)治療腦轉移瘤療效.方法 迴顧性分析51例腦轉移瘤FSRT+WBRT和35例腦轉移瘤單純WBRT的結果,比較分析兩者有效率、生存率的差異.結果 FSRT+WBRT、WBRT組完全緩解率分彆為49%、26%(P<0.05),中位生存期分彆為(11.0±1.5)、(6.5±0.5)箇月(P<0.05),18箇月生存率分彆為24%、9%(P<0.05).兩組有效率(8%、71%,P0.05)和6、12箇月生存率(63%、41%,51%、23%,P0.05)相似.結論 X刀FSRT聯閤WBRT治療腦轉移瘤損傷小、安全、延長生存期,療效優于單純全顱放療.
목적 분석X도분차입체정향방료(FSRT)연합전뇌조사(WBRT)치료뇌전이류료효.방법 회고성분석51례뇌전이류FSRT+WBRT화35례뇌전이류단순WBRT적결과,비교분석량자유효솔、생존솔적차이.결과 FSRT+WBRT、WBRT조완전완해솔분별위49%、26%(P<0.05),중위생존기분별위(11.0±1.5)、(6.5±0.5)개월(P<0.05),18개월생존솔분별위24%、9%(P<0.05).량조유효솔(8%、71%,P0.05)화6、12개월생존솔(63%、41%,51%、23%,P0.05)상사.결론 X도FSRT연합WBRT치료뇌전이류손상소、안전、연장생존기,료효우우단순전로방료.
Objective To evaluate efficiency of brain metastases tumor using X-knife under farctionational stereotactie radiotherapy (FSRT) combine with whole brain radiotherapy (WBRT). Methods Retrospective comparing 51 patients treated by FSRT plus WBRT (FSRT + WBRT group) with 35 patients treated by WBRT alone (WBRT group) on the effecting rate and survival rate. Results The completeness response rate was 49 % and 26 % (P < 0.05) in FSRT + WBRT and WBRT groups, respectively. The effecting rate was 80 % and 71 % (P 0.05) in FSRT + WBRT and WBRT groups, respectively. The middle survival time was (11.0 ± 1.5) months and (6.5 ± 0.5) months (P < 0.05) in FSRT + WBRT and WBRT groups, respeetivley. The 0.5-, 1.0- and 1.5-years survival rate was 63 % and 41 % (P 0.05), 51 % and 23 % (P 0.05) and 24 % and 9 % (P < 0.05) in FSRT + WBRT and WBRT groups, respectively. Conclusions The method with FSRT plus WBRT in the treatment of brain metastases tumor is safe and relieved focal symptom of patients quickly with lesser injury on normal tissue and the survival time be prolonged, it has better therapeutic effects than WBRT alone for treating brain metastases tumor.